These considerations on efficacy and effectiveness are based on studies measuring prevention of mild to moderate COVID-19 infection; they were not designed to conclude on prevention of hospitalisation, severe disease, or death, or on prevention of infection and transmission potential. Assessing the suitability of vaccines must consider all indicators, and involve safety, deployability, availability, and costs.
Basically we only wanted to look at the number of reduced sniffles cases, not how many hospitalizations or deaths this is causing...
These considerations on efficacy and effectiveness are based on studies measuring prevention of mild to moderate COVID-19 infection; they were not designed to conclude on prevention of hospitalisation, severe disease, or death, or on prevention of infection and transmission potential. Assessing the suitability of vaccines must consider all indicators, and involve safety, deployability, availability, and costs.
Basically we only wanted to look at the number of reduced sniffles cases, not how many hospitalizations or deaths this is causing...
So they can still report severe cases and deaths, while at the same time reporting how well the vaccines work....